Access cutting-edge liver failure treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access liver failure specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver failure treatment provided free
A Phase 2, multi-center, randomized, controlled, open-label study to evaluate the effects of the intraperitoneal, liposomal formulation VS-01 in patients with an acute episode of hepatic and/or extrahepatic organ dysfunctions and failures in the presence of liver cirrhosis (Acute-on-Chronic Liver Failure, ACLF) and accumulation of fluid in the abdominal cavity (ascites)
Sponsor: Versantis AG
Check if you qualify for this liver failure clinical trial in Washington Dc, DC
If you're searching for liver failure treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.